Skip to main content
TipRanks
Go Ultimate75% OFF

Black Bird Biotech (BBBT) Financial Statements

30 Followers

Black Bird Biotech Financial Overview

Black Bird Biotech's market cap is currently $3.73K. The company's EPS TTM is $-0.00; its P/E ratio is -0.02; Black Bird Biotech has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue$ 82.56K$ 104.46K$ 57.60K$ 17.77K$ 0.00
Gross Profit$ -55.91K$ 19.59K$ 29.36K$ -31.00$ 0.00
Operating Income$ -1.29M$ -1.45M$ -684.80K$ -80.31K$ -83.54K
EBITDA$ -1.20M$ -1.42M$ -684.28K$ -146.08K$ -82.99K
Net Income$ -1.66M$ -1.81M$ -691.57K$ -163.63K$ -121.11K
Balance Sheet
Cash & Short-Term Investments$ 44.45K$ 499.77K$ 52.97K$ 973.00$ 4.73K
Total Assets$ 218.51K$ 774.20K$ 126.15K$ 973.00$ 4.73K
Total Debt$ 669.77K$ 58.33K$ 45.62K$ 874.57K$ 792.01K
Net Debt$ 625.33K$ -441.43K$ -7.36K$ 873.60K$ 787.27K
Total Liabilities$ 868.68K$ 103.99K$ 98.54K$ 1.14M$ 1.02M
Stockholders' Equity$ -650.17K$ 670.21K$ 27.61K$ -1.14M$ -1.02M
Cash Flow
Free Cash Flow$ -1.03M$ -998.13K$ -619.47K$ -86.33K$ -76.10K
Operating Cash Flow$ -1.03M$ -992.43K$ -619.47K$ -86.33K$ -76.10K
Investing Cash Flow$ 0.00$ -185.70K$ -20.00K$ 0.00$ 0.00
Financing Cash Flow$ 577.26K$ 1.62M$ 606.47K$ 82.56K$ 79.26K

Currency in USD

Black Bird Biotech Earnings and Revenue History

-2M-1M01M-2400 %-1800 %-1200 %-600 %EarningsProfit Margin201720182019202020212022RevenueEarningsProfit Margin

Black Bird Biotech Liabilities to Assets

0400K800K1.2M0 %50000 %100000 %150000 %LiabilitiesLiabilities to Assets201720182019202020212022AssetsLiabilitiesLiabilities to Assets

Black Bird Biotech Cash Flow

-1.5M-1M-500K0500K1M1.5M2M201720182019202020212022OperatingInvestingFinancing

Black Bird Biotech Forecast EPS vs Actual EPS